REQUEST A DEMO
Total
USD $0.00
Search more companies

Medfray Medical Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Medfray Medical Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Medfray Medical Sdn. Bhd. is a company in Malaysia, with a head office in Kuala Lumpur. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on July 20, 2016. There was a net sales revenue increase of 108.95% reported in Medfray Medical Sdn. Bhd.’s latest financial highlights for 2022. Its’ total assets recorded a growth of 95.74%. In 2022, Medfray Medical Sdn. Bhd.’s net profit margin increased by 3.38%.

Headquarters
10-3-1, 3Rd Floor,, Queen'S Avenue, Block 10,, Jalan Shelley,
Kuala Lumpur; Federal Territories; Postal Code: 55100

Contact Details: Purchase the Medfray Medical Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Medfray Medical Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Medfray Medical Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Medfray Medical Sdn. Bhd. report to view the information.
Incorporation Date:
July 20, 2016
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Medfray Medical Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
108.95%
Total operating revenue
108.95%
Operating profit (EBIT)
234.77%
EBITDA
205.11%
Net Profit (Loss) for the Period
216.29%
Total assets
95.74%
Total equity
63.97%
Operating Profit Margin (ROS)
5.2%
Net Profit Margin
3.38%
Return on Equity (ROE)
13.97%
Debt to Equity Ratio
35.08%
Quick Ratio
-0.4%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?